Cormorant Asset Management

Cormorant Asset Management

Cormorant Asset Management

Xconomy

Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B

$85,000,000 Venture capital (Series C)
FinSMEs

Olema Oncology Raises $85M in Series C Financing

$64,000,000 Undisclosed
FinSMEs

Galecto Raises US$64M in Funding

$96,000,000 Venture capital (Series B)
Xconomy

Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs

DealStreetAsia , Pulse 2.0

China’s Wu Capital leads $91.5m Series A round in genetic firm Korro Bio

$91,500,000 Venture capital (Series A)
FinSMEs

Korro Bio Closes $91.5M Series A Financing

$36,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Erasca Completes $36M Extension of Series B Financing

Xconomy

Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More

$270,000,000 Venture capital (Series C)
FinSMEs , ChinaMoneyNetwork

Freenome Closes $270M Series C Financing

Pulse 2.0

Targeted Cancer Therapy Biotech Company Tango Therapeutics Raises $50 Million 

Xconomy

Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor

$50,000,000 Venture capital
FinSMEs

Tango Therapeutics Raises $50M in Equity Financing

Xconomy

Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia

$54,000,000 Venture capital (Series B)
Pulse 2.0 , FinSMEs

Olema Oncology Secures $54 Million To Advance Lead Program In Breast Cancer

$72,500,000 Venture capital (Series D)
FinSMEs

BioAtla Raises $72.5M In Series D Financing

$30,000,000 Venture capital (Series E)
DealStreetAsia

China Deal Monitor: New Horizon Health snags funding and more updates

$102,000,000 Venture capital (Series D)
Crunchbase News , DealStreetAsia

GreenLight Biosciences Closes $102M Series D To Expand RNA Products

$150,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

C4 Therapeutics Raises $170M in Funding

Xconomy

Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs

$55,000,000 Venture capital (Series C)
FinSMEs , Pulse 2.0

Bigfoot Biomedical Closes $55M Series C Financing